ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 125 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $146,158 | -14.5% | 22,625 | -0.2% | 0.00% | 0.0% |
| Q1 2023 | $170,992 | -90.0% | 22,678 | -86.5% | 0.00% | -90.0% |
| Q4 2022 | $1,706,166 | -70.5% | 168,427 | -71.2% | 0.01% | -68.8% |
| Q3 2022 | $5,776,000 | +37.2% | 583,981 | +47.7% | 0.03% | +23.1% |
| Q2 2022 | $4,210,000 | +75.3% | 395,332 | +60.5% | 0.03% | +30.0% |
| Q1 2022 | $2,401,000 | -36.1% | 246,303 | -6.2% | 0.02% | -44.4% |
| Q4 2021 | $3,756,000 | +408.3% | 262,686 | +612.4% | 0.04% | +300.0% |
| Q3 2021 | $739,000 | -87.1% | 36,874 | -85.8% | 0.01% | -86.2% |
| Q2 2021 | $5,728,000 | +337.6% | 260,359 | +575.4% | 0.06% | +282.4% |
| Q1 2021 | $1,309,000 | – | 38,550 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $28,452,416 | 91.13% |
| Founders Fund Growth Management, LLC | 407,017 | $3,068,908 | 14.23% |
| Gruss & Co., LLC | 167,500 | $1,262,950 | 7.99% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $30,952,416 | 3.25% |
| Belmont Capital, LLC | 510,000 | $3,845,400 | 3.18% |
| Prosight Management, LP | 753,528 | $5,681,601 | 2.69% |
| Intellectus Partners, LLC | 872,483 | $6,578,520 | 2.08% |
| Casdin Capital, LLC | 2,520,000 | $19,000,800 | 1.56% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $13,022,958 | 1.50% |
| Orbimed Advisors | 4,180,768 | $31,522,991 | 0.62% |